| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 3475640
[patent_doc_number] => 05399346
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1995-03-21
[patent_title] => 'Gene therapy'
[patent_app_type] => 1
[patent_app_number] => 8/220175
[patent_app_country] => US
[patent_app_date] => 1994-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 9
[patent_no_of_words] => 9669
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/399/05399346.pdf
[firstpage_image] =>[orig_patent_app_number] => 220175
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/220175 | Gene therapy | Mar 29, 1994 | Issued |
| 08/213668 | POLYMERIC GENE DELIVERY SYSTEM | Mar 14, 1994 | Abandoned |
Array
(
[id] => 3728878
[patent_doc_number] => 05652223
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-07-29
[patent_title] => 'DNA encoding CAI resistance proteins and uses thereof'
[patent_app_type] => 1
[patent_app_number] => 8/212190
[patent_app_country] => US
[patent_app_date] => 1994-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 16208
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 98
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/652/05652223.pdf
[firstpage_image] =>[orig_patent_app_number] => 212190
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/212190 | DNA encoding CAI resistance proteins and uses thereof | Mar 13, 1994 | Issued |
| 08/212394 | TARGETED DELIVERY OF GENES ENCODING SERETORY PROTEINS | Mar 10, 1994 | Abandoned |
Array
(
[id] => 3610653
[patent_doc_number] => 05589581
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-12-31
[patent_title] => 'DNA sequences useful for the synthesis of carotenoids'
[patent_app_type] => 1
[patent_app_number] => 8/209617
[patent_app_country] => US
[patent_app_date] => 1994-03-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 10529
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/589/05589581.pdf
[firstpage_image] =>[orig_patent_app_number] => 209617
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/209617 | DNA sequences useful for the synthesis of carotenoids | Mar 9, 1994 | Issued |
Array
(
[id] => 3704469
[patent_doc_number] => 05654167
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-08-05
[patent_title] => 'Antimicrobial proteins, compositions containing same and uses thereof'
[patent_app_type] => 1
[patent_app_number] => 8/208181
[patent_app_country] => US
[patent_app_date] => 1994-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 24
[patent_no_of_words] => 10821
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/654/05654167.pdf
[firstpage_image] =>[orig_patent_app_number] => 208181
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/208181 | Antimicrobial proteins, compositions containing same and uses thereof | Mar 7, 1994 | Issued |
Array
(
[id] => 3557145
[patent_doc_number] => 05543507
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-08-06
[patent_title] => 'Covalently cross-linked oligonucleotides'
[patent_app_type] => 1
[patent_app_number] => 8/205507
[patent_app_country] => US
[patent_app_date] => 1994-03-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 37626
[patent_no_of_claims] => 77
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/543/05543507.pdf
[firstpage_image] =>[orig_patent_app_number] => 205507
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/205507 | Covalently cross-linked oligonucleotides | Mar 1, 1994 | Issued |
Array
(
[id] => 3421768
[patent_doc_number] => 05422105
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1995-06-06
[patent_title] => 'Use of recombinant colony stimulating factor 1'
[patent_app_type] => 1
[patent_app_number] => 8/204801
[patent_app_country] => US
[patent_app_date] => 1994-03-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 17177
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/422/05422105.pdf
[firstpage_image] =>[orig_patent_app_number] => 204801
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/204801 | Use of recombinant colony stimulating factor 1 | Feb 28, 1994 | Issued |
Array
(
[id] => 3112642
[patent_doc_number] => 05464814
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1995-11-07
[patent_title] => 'Acellular red blood cell substitute'
[patent_app_type] => 1
[patent_app_number] => 8/203505
[patent_app_country] => US
[patent_app_date] => 1994-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 14
[patent_no_of_words] => 10115
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 162
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/464/05464814.pdf
[firstpage_image] =>[orig_patent_app_number] => 203505
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/203505 | Acellular red blood cell substitute | Feb 27, 1994 | Issued |
Array
(
[id] => 3699391
[patent_doc_number] => 05646010
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-07-08
[patent_title] => 'Methods and compositions for expression of competent eukaryotic gene products'
[patent_app_type] => 1
[patent_app_number] => 8/197565
[patent_app_country] => US
[patent_app_date] => 1994-02-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 53
[patent_no_of_words] => 19855
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 118
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/646/05646010.pdf
[firstpage_image] =>[orig_patent_app_number] => 197565
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/197565 | Methods and compositions for expression of competent eukaryotic gene products | Feb 16, 1994 | Issued |
Array
(
[id] => 3479631
[patent_doc_number] => 05445819
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1995-08-29
[patent_title] => 'Biological control of mole crickets (Scapteriscus spp.)'
[patent_app_type] => 1
[patent_app_number] => 8/199348
[patent_app_country] => US
[patent_app_date] => 1994-02-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6299
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 77
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/445/05445819.pdf
[firstpage_image] =>[orig_patent_app_number] => 199348
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/199348 | Biological control of mole crickets (Scapteriscus spp.) | Feb 15, 1994 | Issued |
Array
(
[id] => 3770297
[patent_doc_number] => 05817308
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-10-06
[patent_title] => 'Tolerogenic fusion proteins of immunoglobulins and methods for inducing and maintaining tolerance'
[patent_app_type] => 1
[patent_app_number] => 8/195874
[patent_app_country] => US
[patent_app_date] => 1994-02-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 11
[patent_no_of_words] => 12627
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 74
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/817/05817308.pdf
[firstpage_image] =>[orig_patent_app_number] => 195874
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/195874 | Tolerogenic fusion proteins of immunoglobulins and methods for inducing and maintaining tolerance | Feb 10, 1994 | Issued |
Array
(
[id] => 3516377
[patent_doc_number] => 05512660
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-04-30
[patent_title] => 'Purified ICAM-2 and fragment thereof'
[patent_app_type] => 1
[patent_app_number] => 8/194613
[patent_app_country] => US
[patent_app_date] => 1994-02-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 11
[patent_no_of_words] => 15679
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/512/05512660.pdf
[firstpage_image] =>[orig_patent_app_number] => 194613
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/194613 | Purified ICAM-2 and fragment thereof | Feb 9, 1994 | Issued |
Array
(
[id] => 3589405
[patent_doc_number] => 05550214
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-08-27
[patent_title] => 'Isolated antigenic oncogene peptide fragments and uses'
[patent_app_type] => 1
[patent_app_number] => 8/195075
[patent_app_country] => US
[patent_app_date] => 1994-02-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 8
[patent_no_of_words] => 17471
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/550/05550214.pdf
[firstpage_image] =>[orig_patent_app_number] => 195075
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/195075 | Isolated antigenic oncogene peptide fragments and uses | Feb 9, 1994 | Issued |
Array
(
[id] => 3456930
[patent_doc_number] => 05472871
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1995-12-05
[patent_title] => 'Isolation and characterization of the nematode HER-1 Gene and protein product'
[patent_app_type] => 1
[patent_app_number] => 8/194180
[patent_app_country] => US
[patent_app_date] => 1994-02-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 7
[patent_no_of_words] => 18569
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/472/05472871.pdf
[firstpage_image] =>[orig_patent_app_number] => 194180
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/194180 | Isolation and characterization of the nematode HER-1 Gene and protein product | Feb 8, 1994 | Issued |
| 08/192808 | NEURITE-PROMOTING FACTOR AND PROCESS FOR THE MANUFACTURE THEREOF | Feb 7, 1994 | Abandoned |
| 08/192274 | USES OF GREEN FLUORESCENT PROTEIN | Feb 3, 1994 | Abandoned |
| 08/183099 | METHOD FOR PURIFYING COLONY STIMULATING FACTOR PROTEIN AND SUBSTANTIALLY PURE CSF PROTEIN OBTAINED THEREBY | Jan 13, 1994 | Abandoned |
| 08/180701 | TRANSKARYOTIC IMPLANTATION | Jan 12, 1994 | Abandoned |
| 08/179873 | NOVEL HUMAN MAST CELL-DERIVED POLYPEPTIDES (HMC-DPS), THEIR PRODUCTION AND USES | Jan 10, 1994 | Abandoned |